Predicting Drug-Disease Associations via Using Gaussian Interaction Profile and Kernel-Based Autoencoder.

Computational drug repositioning, designed to identify new indications for existing drugs, significantly reduced the cost and time involved in drug development. Prediction of drug-disease associations is promising for drug repositioning. Recent years have witnessed an increasing number of machine le...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International pp. 1 - 12
Autores principales: Jiang, Han-Jing, Huang, Yu-An, You, Zhu-Hong
Formato: equations & formulas pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell 8/27/2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138290878&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 138290878
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 8/27/2019
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        138290878
        138290878
        138290878
        10.1155/2019/2426958
        138290878
      ppf: 1
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Predicting Drug-Disease Associations via Using Gaussian Interaction Profile and Kernel-Based Autoencoder.
      aug:
        au:
          Jiang, Han-Jing
          Huang, Yu-An
          You, Zhu-Hong
        affil: Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Science, Urumqi 830011, China
      sug:
        subj:
          Neural Networks (Computer) Methods
          Machine Learning Methods
          Autoencoder Utilization
          Bioinformatics Methods
          Drug Design Methods
          Human
          Drug Design Economics
          Obesity Drug Therapy
          Alzheimer's Disease Drug Therapy
      ab: Computational drug repositioning, designed to identify new indications for existing drugs, significantly reduced the cost and time involved in drug development. Prediction of drug-disease associations is promising for drug repositioning. Recent years have witnessed an increasing number of machine learning-based methods for calculating drug repositioning. In this paper, a novel feature learning method based on Gaussian interaction profile kernel and autoencoder (GIPAE) is proposed for drug-disease association. In order to further reduce the computation cost, both batch normalization layer and the full-connected layer are introduced to reduce training complexity. The experimental results of 10-fold cross validation indicate that the proposed method achieves superior performance on Fdataset and Cdataset with the AUCs of 93.30% and 96.03%, respectively, which were higher than many previous computational models. To further assess the accuracy of GIPAE, we conducted case studies on two complex human diseases. The top 20 drugs predicted, 14 obesity-related drugs, and 11 drugs related to Alzheimer's disease were validated in the CTD database. The results of cross validation and case studies indicated that GIPAE is a reliable model for predicting drug-disease associations.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N